For Immediate Release
Media Contact: Bob Cooper
Date: June 18, 2003
Purchasers of BuSpar May Now File Claims for Monetary Payment
(Boise) - Attorney General Lawrence Wasden is joining a national announcement today that Idaho consumers who purchased the anti-anxiety drug BuSpar may now file claims for restitution. The restitution payments are a result of an antitrust suit that was settled on March 7, 2003 against Bristol-Myers Squibb Co., Watson Pharma, Inc. and Danbury Pharmacal, Inc.
Idahoans and organizations that purchased BuSpar between January 1, 1998 and January 31, 2003 may be eligible to receive payment. If you purchased BuSpar during that time period, you may access the claim form from our web site by clicking here or call toll–free (800) 678–9587.
The deadline to file a claim is October 10, 2003.
"Individual Idahoans and governmental entities paid too much for BuSpar and deserve the refunds available through the settlement," Attorney General Wasden said. "I urge any purchasers of this drug to review the claims information and consider filing a claim."
Idaho and 34 other states, the District of Columbia and Puerto Rico, had alleged that Bristol and the other defendants acted in violation of state and federal antitrust laws to prevent generic BuSpar from coming to market.
The State of Idaho will also receive $175,000 based upon Medicaid and state agency purchases of BuSpar.
- End -
NOTE TO READERS - This settlement information has expired and is no longer available.